# Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study

> **NCT00271934** · PHASE2 · COMPLETED · sponsor: **Northwestern University** · enrollment: 52 (actual)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **BIOLOGICAL:** Immune ablation and hematopoietic stem cell support.

## Key facts

- **NCT ID:** NCT00271934
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2007-11
- **Final completion:** 2012-04
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2023-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00271934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00271934, "Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00271934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*